Skip to content
healthcare.dev

Tizanidine

NDC 51655-740, Tizanidine, tablet, from Northwind Health Company, LLC.

Product NDC
51655-740
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076416
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-740 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
51655-740-265165507402690 TABLET in 1 BOTTLE, PLASTIC (51655-740-26)
51655-740-525165507405230 TABLET in 1 BOTTLE, PLASTIC (51655-740-52)
51655-740-545165507405415 TABLET in 1 BOTTLE, PLASTIC (51655-740-54)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f32f399f-42af-f0ba-e053-2a95a90a8c2e

Use it

Look up 51655-740 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-740 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-740. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.